Medicine News and Research

RSS

Researchers discover genetic alterations responsible for Kabuki syndrome

Using a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardation. Instead of sequencing the entire human genome, the new approach sequences just the exome, the 1-2 percent of the human genome that contains protein-coding genes.

16 Aug 2010

CD31 positive cells have potential for treating peripheral artery disease: Research

Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.

16 Aug 2010

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.

13 Aug 2010

UT System Board of Regents approve plans for new University Hospital at UT Southwestern Medical Center

The UT System Board of Regents today gave its approval to plans for a new state-of-the-art University Hospital at UT Southwestern Medical Center in Dallas. The project now will go to the Texas Higher Education Coordinating Board for its review and final approval.

13 Aug 2010

Researchers identify second type of complete sporadic disease

A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy, as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease was reported in the 1920s. The landmark finding from the National Prion Disease Pathology Surveillance Center at Case Western Reserve University is published in the August issue of Annals of Neurology.

13 Aug 2010

ACAM, AAEM sign agreement to host joint conference in Portland

The American College for Advancement in Medicine and the American Academy of Environmental Medicine are excited to announce they have reached an agreement to host a joint conference and tradeshow, November 16 - 20, 2011 in Portland, Oregon.

13 Aug 2010

SANUWAVE second-quarter revenues decrease to $117,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and six months ended June 30, 2010 and provided a business update.

13 Aug 2010

LabCorp announces collaboration between Esoterix Clinical Trials Services, Clearstone Central Laboratories

Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.

13 Aug 2010

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

13 Aug 2010

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

The Cardiovascular Research Foundation has announced that in addition to the previously announced late breaking clinical trials and first reports, a series of additional featured trials will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium. These trials will focus on a wide range of significant topics in interventional cardiovascular medicine. TCT 2010 will take place September 21 - 25 in Washington, DC.

13 Aug 2010

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.

13 Aug 2010

National organization releases “Lessons from the Frontlines” report on H1N1

The Canadian Medical Association (CMA), the College of Family Physicians of Canada (CFPC), and the National Specialty Society of Community Medicine (NSSCM) today released Lessons from the Frontlines, a collaborative report on H1N1 describing the physician experience on the frontlines of the pandemic.

13 Aug 2010

UMass Memorial selects McKesson's CytoCare robot to automate compounding of hazardous IV drugs

UMass Memorial Medical Center in Massachusetts has selected the CytoCare™ robot from McKesson to automate the compounding of intravenous (IV) drugs. The robotic technology will enable the 830-bed facility to more safely prepare hazardous IVs, protecting both their patients and their staff from exposure risks.

13 Aug 2010

Research reveals self-care improves healing experience

New research conducted by Experience In Motion LLC (EIM), Minneapolis, reveals that when healthcare organizations, their staff and practitioners engage in self-care as an organizational strategy, it not only improves the healing experience for themselves and patients, but it also improves business measures.

13 Aug 2010

MedAssurant enters agreement with NCQA to develop new measures of healthcare quality

MedAssurant Inc., a leading provider of data-driven healthcare solutions, today announced that it has entered into a definitive agreement with the National Committee for Quality Assurance, the organization that maintains the Healthcare Effectiveness Data and Information Set (HEDIS ®)—the most widely used performance measurement tool in healthcare and a core component of the Medicare Star Rating system—to support the development of new measures of healthcare quality that NCQA is developing under a contract it has with the Centers for Medicare & Medicaid Services.

13 Aug 2010

Mount Sinai receives grant from NIH to continue research on food allergy

Mount Sinai School of Medicine today announced that the National Institutes of Health (NIH) has renewed its funding of the Consortium of Food Allergy Research (CoFAR), providing an additional $29.9 million toward genetic research and the prevention and treatment of food allergy. Mount Sinai is the primary research site for CoFAR, leading seven other institutions around the country.

13 Aug 2010

NewCardio second-quarter net loss decreases to $1.5 million

NewCardio, Inc., a cardiac diagnostic technology provider, today announced financial results for the second quarter ended June 30, 2010.

13 Aug 2010

Study identifies use of acetaminophen may increase asthma symptoms in adults

New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with a 50 percent increase in the risk of asthma.

13 Aug 2010

AHRQ selects Outcome Sciences to study effects of different treatments for open angle glaucoma

Outcome Sciences, Inc. (OUTCOME), the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that the Agency for Healthcare Research and Quality (AHRQ) has selected Outcome as the DEcIDE Center for a study designed to compare the effectiveness of medications versus surgery for the treatment of open-angle glaucoma. The study will enroll 2,600 patients from 30 sites across the United States and is intended to provide new scientific information about the effects of different treatment approaches in individuals who have glaucoma.

13 Aug 2010

NAC to deliver education program on asthma management for youth

As children with asthma head back to school this fall, the National Asthma Campaign Foundation (NAC) is partnering with Respiratory Health Association of Metropolitan Chicago (RHAMC) to deliver Fight Asthma Now (FAN), an asthma education program that teaches youth to control and manage their asthma.

13 Aug 2010

Medicine News and Research

Researchers discover genetic alterations responsible for Kabuki syndrome

CD31 positive cells have potential for treating peripheral artery disease: Research

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

UT System Board of Regents approve plans for new University Hospital at UT Southwestern Medical Center

Researchers identify second type of complete sporadic disease

ACAM, AAEM sign agreement to host joint conference in Portland

SANUWAVE second-quarter revenues decrease to $117,000

LabCorp announces collaboration between Esoterix Clinical Trials Services, Clearstone Central Laboratories

Catalyst second-quarter net loss decreases to $1,328,541

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

National organization releases “Lessons from the Frontlines” report on H1N1

UMass Memorial selects McKesson's CytoCare robot to automate compounding of hazardous IV drugs

Research reveals self-care improves healing experience

MedAssurant enters agreement with NCQA to develop new measures of healthcare quality

Mount Sinai receives grant from NIH to continue research on food allergy

NewCardio second-quarter net loss decreases to $1.5 million

Study identifies use of acetaminophen may increase asthma symptoms in adults

AHRQ selects Outcome Sciences to study effects of different treatments for open angle glaucoma

NAC to deliver education program on asthma management for youth

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News